Glysolin 30/70 Description

Recombinant Biphasic Isophane Insulin (Glysolin 30/70) is a recombinant human insulin, synthesized in a laboratory strain of Hansenula polymorphia (a yeast), in which the gene for human insulin has been inserted by the recombinant DNA technique. It is a mixture of insulin human regular injection 30% with isophane insulin human suspension 70% and providing an intermediate-acting insulin with an onset of action similar to regular insulin (0.5 hours). The onset of action of Biphasic Isophane insulin (Glysolin 30/70) is dependent on dose, site of injection, blood supply, temperature and physical activity. The duration of effect is about 18-24 hour. The time course of action of any insulin may vary considerably in different individual or at different times in the same individual. It is a sterile solution and is for subcutaneous injection only. It should not be used intravenously or intramuscularly.
Each mL contains: 100 IU Insulin Human USP (30% Regular insulin human neutral and 70% Isophane insulin); 0.16% ^w/_v m-Cresol (as preservative); 0.065% ^w/_v Phenol (as preservative); Water for injection.